The Single Best Reason to Buy Novavax Stock Now
Buy the rumor and sell the news doesn't always work out so well.
Investors who followed the old adage with Novavax (NASDAQ: NVAX) recently learned that lesson the hard way. Shares of the clinical-stage biotech surged after the company announced that it would provide a clinical update for its RSV F vaccine. Many clearly thought that Novavax would deliver some good news for its beleaguered program.
When the update actually happened, though, it was a different story for the stock. Shares gave up all the gains and then some as investors realized the news for the RSV F vaccine didn't justify the previous bounce. With the latest round of drama over, what's the best course of action?
Source: Fool.com
Novavax Inc. Stock
€11.89
3.550%
With 6 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 21 € shows a very positive potential of 76.65% compared to the current price of 11.89 € for Novavax Inc..
